These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 31807538)
1. Genome-wide profiling of prognosis-related alternative splicing signatures in sarcoma. Hong W; Zhang W; Guan R; Liang Y; Hu S; Ji Y; Liu M; Lu H; Yu M; Ma L Ann Transl Med; 2019 Oct; 7(20):557. PubMed ID: 31807538 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer. Yu S; Hu C; Liu L; Cai L; Du X; Yu Q; Lin F; Zhao J; Zhao Y; Zhang C; Liu X; Li W J Transl Med; 2020 Jul; 18(1):286. PubMed ID: 32723333 [TBL] [Abstract][Full Text] [Related]
3. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma. Lai J; Yang H; Xu T BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases. He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data. Ye P; Yang Y; Zhang L; Zheng G Front Oncol; 2021; 11():658262. PubMed ID: 34676158 [TBL] [Abstract][Full Text] [Related]
6. Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data. Zhou YJ; Zhu GQ; Zhang QW; Zheng KI; Chen JN; Zhang XT; Wang QW; Li XB DNA Cell Biol; 2019 Nov; 38(11):1207-1222. PubMed ID: 31483163 [TBL] [Abstract][Full Text] [Related]
7. Identification of drug targets and prognosis projection for uterine carcinosarcoma based on alternative splicing events. Zhang X; Yin X; Zhang L; Ye Z; Liang G Comput Biol Med; 2023 Jan; 152():106346. PubMed ID: 36470146 [TBL] [Abstract][Full Text] [Related]
8. Characterization of alternative splicing events and prognostic signatures in breast cancer. Han P; Zhu J; Feng G; Wang Z; Ding Y BMC Cancer; 2021 May; 21(1):587. PubMed ID: 34022836 [TBL] [Abstract][Full Text] [Related]
9. Novel Insights Into Triple-Negative Breast Cancer Prognosis by Comprehensive Characterization of Aberrant Alternative Splicing. Gong S; Song Z; Spezia-Lindner D; Meng F; Ruan T; Ying G; Lai C; Wu Q; Liang Y Front Genet; 2020; 11():534. PubMed ID: 32595697 [TBL] [Abstract][Full Text] [Related]
10. Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma. Liu Y; Jia W; Li J; Zhu H; Yu J Front Oncol; 2020; 10():587343. PubMed ID: 33117720 [No Abstract] [Full Text] [Related]
11. Systematic analysis and prediction model construction of alternative splicing events in hepatocellular carcinoma: a study on the basis of large-scale spliceseq data from The Cancer Genome Atlas. Yang L; He Y; Zhang Z; Wang W PeerJ; 2019; 7():e8245. PubMed ID: 31844595 [TBL] [Abstract][Full Text] [Related]
12. Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer. Yu M; Hong W; Ruan S; Guan R; Tu L; Huang B; Hou B; Jian Z; Ma L; Jin H Front Oncol; 2019; 9():773. PubMed ID: 31552163 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Value and Potential Role of Alternative mRNA Splicing Events in Cervical Cancer. Shao XY; Dong J; Zhang H; Wu YS; Zheng L Front Genet; 2020; 11():726. PubMed ID: 32793282 [TBL] [Abstract][Full Text] [Related]
14. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma. Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607 [TBL] [Abstract][Full Text] [Related]
15. Systematic Profile Analysis of Prognostic Alternative Messenger RNA Splicing Signatures and Splicing Factors in Head and Neck Squamous Cell Carcinoma. Xing L; Zhang X; Tong D DNA Cell Biol; 2019 Jul; 38(7):627-638. PubMed ID: 31025877 [TBL] [Abstract][Full Text] [Related]
16. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas. Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718 [TBL] [Abstract][Full Text] [Related]
17. Novel insights into clear cell renal cell carcinoma prognosis by comprehensive characterization of aberrant alternative splicing signature: a study based on large-scale sequencing data. Zhang D; Zhang W; Sun R; Huang Z Bioengineered; 2021 Dec; 12(1):1091-1110. PubMed ID: 33783315 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases. Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199 [TBL] [Abstract][Full Text] [Related]
19. Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer. Xu L; Pan J; Ding Y; Pan H Front Genet; 2020; 11():522383. PubMed ID: 33193606 [TBL] [Abstract][Full Text] [Related]
20. Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods. Cai Q; He B; Zhang P; Zhao Z; Peng X; Zhang Y; Xie H; Wang X J Transl Med; 2020 Dec; 18(1):463. PubMed ID: 33287830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]